Detection of Left Ventricular Thrombus by Delayed-Enhancement Cardiovascular Magnetic Resonance. Prevalence and Markers in Patients With Systolic Dysfunction

Journal of the American College of Cardiology

Volumn 52, Issue 2, 2008, Pages 148-157

  Weinsaft, Jonathan W ^a   Kim, Han W ^a   Shah, Dipan J ^a,b   Klem, Igor ^a   Crowley, Anna Lisa ^a   Brosnan, Rhoda ^a   James, Olga G ^a,b   Patel, Manesh R ^a   Heitner, John ^a   Parker, Michele ^a   Velazquez, Eric J ^a   Steenbergen, Charles ^a   Judd, Robert M ^a   Kim, Raymond J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Nashville Cardiovascular Magnetic Resonance Institute   (United States)

Author keywords

cardiovascular magnetic resonance; delayed enhancement imaging; thrombus

Indexed keywords

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREVALENCE; PRIORITY JOURNAL; THROMBUS;

AGED; FEMALE; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; MODELS, CARDIOVASCULAR; NORTH CAROLINA; PREVALENCE; TENNESSEE; THROMBOSIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 45849153884     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.03.041     Document Type: Article

References (30)

1. Koniaris L.S., and Goldhaber S.Z. Anticoagulation in dilated cardiomyopathy. J Am Coll Cardiol 31 (1998) 745-748
2. Gottdiener J.S., Massie B., Ammons S.B., et al. Prevalence of left ventricular thrombus in dilated cardiomyopathy: the WATCH trial. (abstr). J Am Coll Cardiol 41 Suppl:202A (2003)
3. Sharma N.D., McCullough P.A., Philbin E.F., and Weaver W.D. Left ventricular thrombus and subsequent thromboembolism in patients with severe systolic dysfunction. Chest 117 (2000) 314-320
4. Katz S.D., Marantz P.R., Biasucci L., et al. Low incidence of stroke in ambulatory patients with heart failure: a prospective study. Am Heart J 126 (1993) 141-146
5. Stratton J.R., and Resnick A.D. Increased embolic risk in patients with left ventricular thrombi. Circulation 75 (1987) 1004-1011
6. Domenicucci S., Chiarella F., Bellotti P., Bellone P., Lupi G., and Vecchio C. Long-term prospective assessment of left ventricular thrombus in anterior wall acute myocardial infarction and implications for a rational approach to embolic risk. Am J Cardiol 83 (1999) 519-524
7. Nihoyannopoulos P., Smith G.C., Maseri A., and Foale R.A. The natural history of left ventricular thrombus in myocardial infarction: a rationale in support of masterly inactivity. J Am Coll Cardiol 14 (1989) 903-911
8. Berger A.K., Gottdiener J.S., Yohe M.A., and Guerrero J.L. Epidemiological approach to quality assessment in echocardiographic diagnosis. J Am Coll Cardiol 34 (1999) 1831-1836
9. Thanigaraj S., Schechtman K.B., and Perez J.E. Improved echocardiographic delineation of left ventricular thrombus with the use of intravenous second-generation contrast image enhancement. J Am Soc Echocardiogr 12 (1999) 1022-1026
10. Grothues F., Smith G.C., Moon J.C., et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 90 (2002) 29-34
11. Kirkpatrick J.N., Wong T., Bednarz J.E., et al. Differential diagnosis of cardiac masses using contrast echocardiographic perfusion imaging. J Am Coll Cardiol 43 (2004) 1412-1419
12. Kim R.J., Fieno D.S., Parrish T.B., et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 100 (1999) 1992-2002
13. Mollet N.R., Dymarkowski S., Volders W., et al. Visualization of ventricular thrombi with contrast-enhanced magnetic resonance imaging in patients with ischemic heart disease. Circulation 106 (2002) 2873-2876
14. Srichai M.B., Junor C., Rodriguez L.L., et al. Clinical, imaging, and pathologic characteristics of left ventricular thrombus: a comparison of contrast enhanced magnetic resonance imaging, transthoracic echocardiography and transesophageal echocardiography with surgical or pathological validation. Am Heart J 152 (2006) 75-84
15. Gibbons R.J., Abrams J., Chatterjee K., et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Chronic Stable Angina). Circulation 107 (2003) 149-158
16. Kadish A., Dyer A., Daubert J.P., et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 350 (2004) 2151-2158
17. Wagner A., Mahrholdt H., Holly T.A., et al. Contrast-enhanced MRI and routine single photon emission computed tomography (SPECT) perfusion imaging for detection of subendocardial myocardial infarctions: an imaging study. Lancet 361 (2003) 374-379
18. Simonetti O.P., Kim R.J., Fieno D.S., et al. An improved MR imaging technique for the visualization of myocardial infarction. Radiology 218 (2001) 215-223
19. Shah D.J., Judd R.M., and Kim R.J. Myocardial viability. In: Edelman R.R., Hesselink J.R., Zlatkin M.B., et al. (Eds). Clinical Magnetic Resonance Imaging. 3rd edition (2006), Elsevier, New York, NY
20. Albert T.S., Kim R.J., and Judd R.M. Assessment of no-reflow regions using cardiac MRI. Basic Res Cardiol 101 (2006) 383-390
21. Asinger R.W., Mikell F.L., Elsperger J., and Hodges M. Incidence of left-ventricular thrombosis after acute transmural myocardial infarction. Serial evaluation by two-dimensional echocardiography. N Engl J Med 305 (1981) 297-302
22. Stratton J.R., Lighty Jr. G.W., Pearlman A.S., and Ritchie J.L. Detection of left ventricular thrombus by two-dimensional echocardiography: sensitivity, specificity, and causes of uncertainty. Circulation 66 (1982) 156-166
23. Sievers B., Elliott M.D., Hurwitz L.M., et al. Rapid detection of myocardial infarction by subsecond, free-breathing delayed contrast-enhancement cardiovascular magnetic resonance. Circulation 115 (2007) 236-244
24. Massie B.M., and Shah N.B. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 133 (1997) 703-712
25. Loh E., Sutton M.S., Wun C.C., et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med 336 (1997) 251-257
26. Hurlen M., Abdelnoor M., Smith P., Erikssen J., and Arnesen H. Warfarin, aspirin, or both after myocardial infarction. N Engl J Med 347 (2002) 969-974
27. Paydarfar D., Krieger D., Dib N., et al. In vivo magnetic resonance imaging and surgical histopathology of intracardiac masses: distinct features of subacute thrombi. Cardiology 95 (2001) 40-47
28. Johannessen K.A., Nordrehaug J.E., von der Lippe G., and Vollset S.E. Risk factors for embolisation in patients with left ventricular thrombi and acute myocardial infarction. Br Heart J 60 (1988) 104-110
29. Visser C.A., Kan G., Meltzer R.S., Lie K.I., and Durrer D. Long-term follow-up of left ventricular thrombus after acute myocardial infarction. A two-dimensional echocardiographic study in 96 patients. Chest 86 (1984) 532-536
30. Spirito P., Bellotti P., Chiarella F., Domenicucci S., Sementa A., and Vecchio C. Prognostic significance and natural history of left ventricular thrombi in patients with acute anterior myocardial infarction: a two-dimensional echocardiographic study. Circulation 72 (1985) 774-780